Aliath Bioventures appoints Dr Philippe Monteyne and announces additional hires to further strengthen its Life Sciences Impact business

September 19, 2023

  • Aliath Bioventures, the healthcare impact investment platform of AltamarCAM Partners, appoints Philippe Monteyne, MD, PhD as a new Partner to reinforce the company’s healthcare investment team. As of 16th November 2023, Philippe Monteyne will join the team responsible for Alta Life Sciences Spain I FCR and the newly launched, ACP Aliath Bioventures II FCR (ABV II), specialised in investing in companies in the healthcare sector. For the past eight years, Philippe has been a Senior Partner of the private equity fund Fund+ in Belgium, having contributed to multiple investments including very profitable ones such as Ogeda and Iteos.
  • The firm also reinforces the life sciences team with the appointment of Joana Correia as a senior analyst that join Beatriz Gandarias, Jose Maria Fern√°ndez and the Alta Life Sciences team

Read more